Clinical Implication Of CD200 In Chronic Lymphoproliferative Disorders
Rasha Farag Mohamed Shedid;
Abstract
Summary
Immune evasion in cancer is increasingly recognized as a contributing factor in the failure of a natural host antitumor immune response as well as in the failure of cancer vaccine trials. Immune evasion may be the result of a number of fa
Immune evasion in cancer is increasingly recognized as a contributing factor in the failure of a natural host antitumor immune response as well as in the failure of cancer vaccine trials. Immune evasion may be the result of a number of fa
Other data
| Title | Clinical Implication Of CD200 In Chronic Lymphoproliferative Disorders | Other Titles | الأهميه الأكلينيكية ل سي دي 200 في حالات التكاثر المزمن للخلايا الليمفاوية | Authors | Rasha Farag Mohamed Shedid | Keywords | Clinical Implication Of CD200 In Chronic Lymphoproliferative Disorders | Issue Date | 2011 | Description | Summary Immune evasion in cancer is increasingly recognized as a contributing factor in the failure of a natural host antitumor immune response as well as in the failure of cancer vaccine trials. Immune evasion may be the result of a number of fa |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.